Loading...
XKRX039840
Market cap164mUSD
Jan 03, Last price  
16,650.00KRW
1D
1.96%
1Q
2.40%
Jan 2017
-57.90%
Name

Dio Corp

Chart & Performance

D1W1MN
XKRX:039840 chart
P/E
73.03
P/S
1.55
EPS
227.99
Div Yield, %
0.00%
Shrs. gr., 5y
0.23%
Rev. gr., 5y
11.35%
Revenues
155.82b
+18.67%
47,870,234,01062,794,873,22061,576,256,27071,939,173,00088,019,747,92891,918,457,99691,043,123,979127,165,198,548120,056,305,947150,037,237,084131,306,346,755155,817,892,643
Net income
3.31b
P
-4,108,927,469-8,270,649,009-3,609,946,3709,252,393,60020,513,688,2188,558,935,9765,454,606,80121,732,481,63611,152,522,48028,254,786,090-20,457,624,6043,311,376,610
CFO
5.44b
P
6,897,902,160-4,100,832,020-317,463,01014,120,282,08011,490,343,9655,644,202,28212,177,430,3929,631,414,59419,084,220,2536,252,772,526-1,025,971,4935,439,420,430
Dividend
Dec 29, 200875 KRW/sh
Earnings
Jan 17, 2025

Profile

DIO Corporation manufactures and sells dental implants in South Korea. It offers implant systems, which include UFII int. submerged and no-submerged systems, FTN external systems, protem mini systems, UV active and activators, and instrument kits. The company also provides dental digital solutions and dental products; and cardiovascular medical devices. In addition, it exports its products to approximately 70 countries. The company was formerly known as DSI Co., Ltd and changed its name to DIO Corporation in August 2008. DIO Corporation was founded in 1988 and is headquartered in Busan, South Korea.
IPO date
Jun 29, 2000
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
155,817,893
18.67%
131,306,347
-12.48%
Cost of revenue
67,829,406
76,542,933
Unusual Expense (Income)
NOPBT
87,988,486
54,763,414
NOPBT Margin
56.47%
41.71%
Operating Taxes
7,786,090
(968,118)
Tax Rate
8.85%
NOPAT
80,202,396
55,731,532
Net income
3,311,377
-116.19%
(20,457,625)
-172.40%
Dividends
Dividend yield
Proceeds from repurchase of equity
(5,153,096)
(3,485,757)
BB yield
1.58%
1.19%
Debt
Debt current
114,104,288
107,377,704
Long-term debt
7,371,106
8,597,283
Deferred revenue
5
1,253,595
Other long-term liabilities
4,359,589
3,727,684
Net debt
90,923,004
75,806,194
Cash flow
Cash from operating activities
5,439,420
(1,025,971)
CAPEX
(4,224,074)
(12,526,143)
Cash from investing activities
(2,866,539)
(16,633,377)
Cash from financing activities
(10,327,124)
5,098,914
FCF
26,216,276
70,883,588
Balance
Cash
11,665,143
22,232,052
Long term investments
18,887,247
17,936,740
Excess cash
22,761,496
33,603,475
Stockholders' equity
79,357,907
98,323,703
Invested Capital
294,113,206
249,323,006
ROIC
29.52%
21.78%
ROCE
27.75%
19.32%
EV
Common stock shares outstanding
14,558
14,823
Price
22,400.00
13.71%
19,700.00
-47.26%
Market cap
326,095,078
11.67%
292,020,862
-46.55%
EV
417,018,082
369,217,486
EBITDA
100,297,515
67,933,222
EV/EBITDA
4.16
5.44
Interest
7,723,685
4,996,081
Interest/NOPBT
8.78%
9.12%